Evidence map›Paper›PMID 29904084›Full record

ArticleScientific reports2018

Signature of Pareto optimization in the Escherichia coli proteome.

Loren Koçillari, Piero Fariselli, Antonio Trovato, Flavio Seno, Amos Maritan

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Design principles of the cytotoxic CD8Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Colloidal stability of the living cell.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Loren KoçillariINFN and Dipartimento di Fisica e Astronomia 'G. Galilei', Università di Padova, Via Marzolo 8, Padova, 35131, IT, Italy.
Piero FariselliDipartimento di Biomedicina Comparata e Alimentazione, Università di Padova, Viale dell' Università 16, Legnaro, 35020, IT, Italy.
Antonio TrovatoINFN and Dipartimento di Fisica e Astronomia 'G. Galilei', Università di Padova, Via Marzolo 8, Padova, 35131, IT, Italy.
Flavio SenoINFN and Dipartimento di Fisica e Astronomia 'G. Galilei', Università di Padova, Via Marzolo 8, Padova, 35131, IT, Italy.
Amos MaritanINFN and Dipartimento di Fisica e Astronomia 'G. Galilei', Università di Padova, Via Marzolo 8, Padova, 35131, IT, Italy. amos.maritan@unipd.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteins have coevolved with cellular environments to improve or preserve their functions, maintaining at the same time the degree of hydrophobicity necessary to fold correctly and enough solubility to perform their biological roles. Here, we study the Escherichia coli proteome using a Pareto front analysis in the solubility-hydrophobicity space. The results indicate the existence of a Pareto optimal front, a triangle whose vertices correspond to archetypal proteins specialized in distinct tasks, such as regulatory processes, membrane transport, outer-membrane pore formation, catalysis, and binding. The vertices are further enriched with proteins that occupy different subcellular compartments, namely, cytoplasmic, inner membrane, outer membrane, and outer membrane bounded periplasmic space. The combination of various enriching features offers an interpretation of how bacteria use the physico-chemical properties of proteins, both to drive them into their final destination in the cell and to have their tasks accomplished.

Indexed as

Models, BiologicalEscherichia coliEscherichia coli ProteinsProteomeEscherichia coli ProteinsProteome

Identifiers

PMID29904084
PMCPMC6002381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.